Advanced Glycation End-Products Downregulate HoxA9EC through Activation of Nuclear Factor Kappa B by Reciprocal Interaction

Publisher： Karger

E-ISSN： 1423-0135|54|4|226-234

ISSN： 1018-1172

Source： Journal of Vascular Research, Vol.54, Iss.4, 2017-07, pp. : 226-234

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Association of S100 calcium‐binding protein A12, receptor for advanced glycation endproducts, and nuclear factor‐κB expression with inflammation in pulp tissues from tooth caries

By  

JOURNAL OF INVESTIGATIVE AND CLINICAL DENTISTRY (ELECTRONIC), Vol. 9, Iss. 1, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Increased Expression of the Receptor for Advanced Glycation End-Products (RAGE) Is Associated with Advanced Breast Cancer Stage

By  

Oncology Research and Treatment, Vol. 39, Iss. 10, 2016-09 ,pp. : 622-628

Karger

Access to resources Recommend Favorite

Role of Advanced Glycation End Products in Aging Collagen

By  

Gerontology, Vol. 44, Iss. 4, 1998-06 ,pp. : 187-191

Karger

Access to resources Recommend Favorite

Advanced Glycation End Products Induce Calcification of Vascular Smooth Muscle Cells through RAGE/p38 MAPK

By  

Journal of Vascular Research, Vol. 46, Iss. 6, 2009-06 ,pp. : 572-580

Karger

Access to resources Recommend Favorite

Celastrol Inhibits Lipopolysaccharide-Induced Angiogenesis by Suppressing TLR4-Triggered Nuclear Factor-Kappa B Activation

By  

Acta Haematologica, Vol. 131, Iss. 2, 2013-10 ,pp. : 102-111

Karger

Access to resources Recommend Favorite